Ambulax Etm 0.25 mg/20 mg Tablet is a combination of two medicines: Etizolam and Propranolol. Etizolam is a benzodiazepine. It works by increasing the action of GABA, a chemical messenger which suppresses the abnormal and excessive activity of the nerve cells in brain. Propranolol is a beta blocker which blocks the action of certain chemical messengers on the heart and blood vessels. This reduces heart rate, blood pressure, and strain on the heart.
Taking Propranolol with alcohol may have additive effects in lowering your blood pressure. You may experience headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate.
WEIGH RISKS VS BENEFITS
Ambulax Etm 0.25 mg/20 mg Tablet may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
No information is available on the use of Ambulax Etm 0.25 mg/20 mg Tablet during lactation. Please consult your doctor.
Do not drive unless you are feeling well. Ambulax Etm 0.25 mg/20 mg Tablet may cause visual disturbances, hallucinations, fatigue, mental confusion, dizziness or tiredness. This may affect your driving ability.
There is limited information available on the use of Ambulax Etm 0.25 mg/20 mg Tablet in patients with kidney disease. Please consult your doctor.
Ambulax Etm 0.25 mg/20 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Ambulax Etm 0.25 mg/20 mg Tablet may be needed. Please consult your doctor. Regular monitoring of blood pressure is advisable for dose adjustment.